TheHEALTH September/October 2024 | Page 9

Cover Story 09
September-October | The HEALTH

Cover Story 09

two to four weeks , with proper care of the rash or blisters being essential to prevent secondary infections .
“ The rash or blisters should be allowed to dry , and exposed blisters should be covered to prevent the spread of fluid ,” he explained .
For high-risk individuals , such as those who are immunocompromised or have underlying health conditions , antiviral medications are available .
Malaysia has acquired Tecovirimat Antiviral ( TPOXX ), a treatment specifically for mpox , particularly for patients with compromised immune systems .
On Sept 2 , 2024 , Health Minister Dr Dzulkefly Ahmad revealed in a series of social media posts that Malaysia would acquire ‘ Tecovirimat Antiviral ( TPOXX )’ and the MVA-BN vaccine through the Covid-19 ASEAN Response Fund .
Malaysia bolsters its defence against Mpox by acquiring the MVA-BN vaccine , which is expected to protect those at higher risk of contracting the virus .
This initiative mirrors similar efforts in neighbouring Indonesia and reflects a growing regional response to the Mpox threat .
The acquisition of both TPOXX and the MVA-BN vaccine is a crucial part of Malaysia ’ s multi-layered approach to combating Mpox .
By ensuring access to both preventive and therapeutic measures , the country is well-positioned to manage any potential rise in Mpox cases , particularly as it continues to monitor developments in the region .
REGIONAL COOPERATION : ASEAN ’ S UNIFIED RESPONSE
Malaysia ’ s efforts to combat Mpox are not occurring in isolation . As part of the broader regional response , the country is working closely with its ASEAN counterparts , demonstrating the power of collective action in the face of a global health threat .
This collaboration has proven invaluable in managing the threat posed by Mpox . On Aug 16 , 2024 , Malaysia activated a special operations room at its National Crisis Preparedness and Response Centre , underscoring the importance of coordinated monitoring efforts across ASEAN .
“ Collaboration among ASEAN countries has been key to managing Mpox .
“ The sharing of information and best practices has allowed us to strengthen surveillance , laboratory capacities , and case management ,” said Dr Suresh .
This regional cooperation extends to monitoring international travellers , particularly those arriving from countries with known outbreaks , such as parts of Africa .
Enhanced screening measures at points of entry and inter-country solid communication have enabled ASEAN nations to remain vigilant against the spread of Mpox .
SCREENING AND VIGILANCE AT ENTRY POINTS
Malaysia ’ s preventive strategy places significant emphasis on point-of-entry screenings .
Travellers arriving from countries affected by Mpox are screened for potential symptoms through thermal scanners and other surveillance measures .
Flight crews and immigration officers have also been trained to report any suspected cases encountered during flights or at immigration counters .
These efforts have been vital in preventing the introduction of Mpox into Malaysia .
“ MoH has strengthened point-of-entry screenings for early detection of suspected Mpox cases ,” explained Dr Suresh .
This level of vigilance , particularly at airports , has allowed Malaysia to act
“ The sharing of information and best practices has allowed us to strengthen surveillance , laboratory capacities , and case management .”
– Dr Suresh
swiftly in isolating suspected cases , preventing community transmission . COMBATING MISINFORMATION In the age of social media , misinformation about Mpox and its transmission has become a growing concern . Some claims , particularly those linking Mpox symptoms to delayed reactions from the Covid-19 vaccine , have gained traction online .
However , health authorities , including Dr Suresh , have been quick to refute such misinformation .
“ Mpox is caused by a different virus altogether ,” he stressed , urging the public to seek accurate information from credible sources .
This clear and direct communication from healthcare professionals is crucial in maintaining public confidence and ensuring that the population is informed about the actual risks associated with Mpox .
As Malaysia continues to monitor the situation , the fight against misinformation will remain an essential aspect of its public health strategy .
MALAYSIA ’ S LONG-TERM PREPAREDNESS
As the world continues to face the threat of emerging and re-emerging infectious diseases , Malaysia ’ s proactive and comprehensive response to Mpox sets a strong precedent for future challenges .
Long-term preparedness , including robust surveillance systems and international collaboration , will be critical in preventing future outbreaks .
Dr Suresh highlighted the importance of a multi-sectoral approach to disease surveillance .
“ Early detection of emerging diseases through collaborative surveillance systems across human , animal , and environmental health sectors is key .”
This holistic approach ensures that Malaysia remains well-prepared to handle not only Mpox but also other infectious diseases that may emerge in the future .
With its combination of advanced laboratory capacities , strong preventive measures , and international collaboration , Malaysia stands at the forefront of global efforts to combat Mpox .
The country ’ s readiness to manage the virus and its commitment to safeguarding public health underscore its resilience in the face of evolving health challenges .
Through continued vigilance , Malaysia is well-positioned to mitigate the threat of Mpox and ensure the safety and well-being of its citizens . – THE HEALTH